Scarica l'app Stockscreener
2.27
0.00%
0.00
Dopo l'orario di chiusura:
2.29
0.02
+0.88%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.27
Aprire:
$2.28
Volume 24 ore:
190.81K
Relative Volume:
2.02
Capitalizzazione di mercato:
$93.08M
Reddito:
$2.70M
Utile/perdita netta:
$5.53M
Rapporto P/E:
20.64
EPS:
0.11
Flusso di cassa netto:
$-10.55M
1 W Prestazione:
-4.22%
1M Prestazione:
-0.87%
6M Prestazione:
+3.18%
1 anno Prestazione:
-6.58%
Intervallo 1D:
$2.19
$2.30
Intervallo di 1 settimana:
$2.19
$2.4698
Portata 52W:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Nome
Oramed Pharmaceuticals Inc
Settore
Industria
Telefono
646-844-1164
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Confronta ORMP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.27 | 96.77M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Iniziato | Canaccord Genuity | Buy |
| 2021-02-09 | Iniziato | National Securities | Buy |
| 2020-12-03 | Iniziato | Alliance Global Partners | Buy |
| 2020-03-11 | Iniziato | Aegis Capital | Buy |
| 2019-09-11 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-12-11 | Ripresa | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Reiterato | FBR Capital | Outperform |
| 2015-12-01 | Reiterato | H.C. Wainwright | Buy |
| 2015-11-19 | Iniziato | FBR Capital | Outperform |
| 2015-04-13 | Ripresa | MLV & Co | Buy |
| 2014-01-30 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Iniziato | MLV & Co | Buy |
| 2013-12-03 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie
How supply chain issues affect Oramed Pharmaceuticals Inc. stockJuly 2025 Gainers & Real-Time Buy Zone Alerts - newser.com
Will Oramed Pharmaceuticals Inc. stock see PE expansion2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
Visualizing Oramed Pharmaceuticals Inc. stock with heatmapsJuly 2025 Volume & Risk Managed Investment Signals - newser.com
Is Oramed Pharmaceuticals Inc. (OJU1) stock ideal for retirement investorsJuly 2025 Review & Risk Controlled Swing Trade Alerts - newser.com
Can Oramed Pharmaceuticals Inc. stock attract ESG capital inflowsTrade Analysis Report & Real-Time Volume Surge Alerts - newser.com
Can technical indicators confirm Oramed Pharmaceuticals Inc.’s reversalWeekly Stock Report & Weekly Setup with High ROI Potential - newser.com
Will breakout in Oramed Pharmaceuticals Inc. lead to full recoveryMarket Performance Summary & Fast Moving Stock Watchlists - newser.com
Will Oramed Pharmaceuticals Inc. stock go up soon2025 Sector Review & Real-Time Buy Signal Notifications - newser.com
Will Oramed Pharmaceuticals Inc. stock outperform Dow Jones indexWeekly Investment Recap & Weekly Watchlist of Top Performers - newser.com
Wealth Enhancement Advisory Services LLC Purchases 5,000 Shares of Oramed Pharmaceuticals Inc. $ORMP - Defense World
Exit strategy if you’re trapped in Oramed Pharmaceuticals Inc.2025 EndofYear Setup & Verified Trade Idea Suggestions - newser.com
Oramed Pharmaceuticals Forms Golden Cross, Signaling Bullish Breakout Ahead - Markets Mojo
Oramed Pharmaceuticals Inc. stock outlook for YEARStop Loss & Expert Verified Movement Alerts - newser.com
What’s the recovery path for long term holders of Oramed Pharmaceuticals Inc.2025 Technical Overview & Real-Time Buy Signal Alerts - newser.com
Weiss Ratings Reaffirms Sell (D) Rating for Oramed Pharmaceuticals (NASDAQ:ORMP) - MarketBeat
Analyzing recovery setups for Oramed Pharmaceuticals Inc. investorsGold Moves & Free AI Powered Buy and Sell Recommendations - newser.com
How to track smart money flows in Oramed Pharmaceuticals Inc.July 2025 Pullbacks & Weekly Market Pulse Updates - newser.com
Is Oramed Pharmaceuticals Inc. stock affected by interest rate hikesWeekly Trade Summary & AI Optimized Trading Strategy Guides - newser.com
Is Oramed Pharmaceuticals Inc OJU1 a good long term investmentPrice Volatility Patterns & Free Double Digit Growth Tips - earlytimes.in
What analysts say about Oramed Pharmaceuticals Inc stockEarnings Season Recap & Small Budget Wealth Building - earlytimes.in
Oramed Pharmaceuticals completes first tranche of Scilex warrant repurchase - Investing.com
Oramed Pharm Completes Warrant Repurchase Agreement - TipRanks
How to forecast Oramed Pharmaceuticals Inc. trends using time seriesQuarterly Earnings Summary & Community Supported Trade Ideas - newser.com
What MACD signals say about Oramed Pharmaceuticals Inc.Weekly Trade Recap & Intraday High Probability Alerts - newser.com
Can Oramed Pharmaceuticals Inc. (OJU1) stock withstand sector downturnsSell Signal & Safe Entry Point Identification - newser.com
What institutional flow reveals about Oramed Pharmaceuticals Inc.2025 Market Overview & Free Accurate Trade Setup Notifications - newser.com
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Short Interest Down 35.7% in September - MarketBeat
Will Oramed Pharmaceuticals Inc. bounce back from current supportWeekly Volume Report & Verified Stock Trade Ideas - newser.com
Can Oramed Pharmaceuticals Inc. stock deliver surprise earnings beatMarket Movers & Fast Exit Strategy with Risk Control - newser.com
Has Oramed Pharmaceuticals Inc. found a price floorJuly 2025 Pullbacks & Real-Time Chart Pattern Alerts - newser.com
Analyzing net buyer seller activity in Oramed Pharmaceuticals Inc.Buy Signal & Technical Pattern Based Signals - newser.com
Using RSI to spot recovery in Oramed Pharmaceuticals Inc.2025 Short Interest & Real-Time Volume Triggers - newser.com
Oramed Pharmaceuticals Inc Azioni (ORMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):